Skip to search formSkip to main contentSkip to account menu

Piperacillin

Known as: Piperacillinum, Pipercillin, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))- 
A broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic. Piperacillin binds to penicillin binding proteins (PBP), the enzymes… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
, isolated from a tertiary care hospital. The study was carried out from January, 2009 - August, 2009, at the Department of… 
2004
2004
Pseudomonas aeruginosa es un patogeno nosocomial frecuente que presenta elevada resistencia a los antimicrobianos y causa… 
1998
1998
OBJECTIVE Continuous hemofiltration is now widely used in the intensive care unit. Our study aimed to assess the removal of… 
1996
1996
The pharmacokinetics of piperacillin, tazobactam and its M1 metabolite were studied in patients with various degrees of renal… 
1985
1985
Nine adult patients with cystic fibrosis, nearly a quarter of the 38 patients with this disease who were treated with… 
1984
1984
The in vitro susceptibilities of 393 recent clinical isolates to WIN 49375, a new quinolone derivative, were determined and… 
1982
1982
Possible antibiotic inactivation was studied in 12 subjects with end-stage renal disease who were undergoing thrice-weekly… 
Highly Cited
1981
Highly Cited
1981
A multilaboratory in vitro study was carried out to determine disk diffusion susceptibility testing quality control limits for… 
1981
1981
Bronchial mucosal biopsies were obtained during fibreoptic bronchoscopy in 12 patients receiving a new semisynthetic penicillin… 
1980
1980
To compare the in vitro activity of moxalactam (LY127935), a new broad-spectrum antimicrobial agent, with cefazolin, amikacin…